Annette R Atkins

This inventor holds 19 USPTO granted patents and 18 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Diabetes Treatment. Top assignees: The Salk Institute, The University of Sydney. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annette R Atkins. Retrieved from https://idiyas.com/inventor/annette-r-atkins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 18)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 40(Granted Patents)

Location History:

San Diego, CA (US) (2018 - 2023)
La Jolla, CA (US) (2017 - 2024)

Company Filing History:

The University of Sydney

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Diabetes

Organoid Generation

FGF Mutant Proteins

Type 1 Diabetes

Type 2 Diabetes

Disease Modeling

Progenitor Compositions

Vitamin D Receptor Agonists

Bromodomain-Containing Proteins

Fexaramine Analogs

Hyperglycemia Treatment

FGF Analog Treatments

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12253527 - Compositions and methods for treating age-related diabetes and related disorders (2025-03-18),

2. 12213999 - Compositions and methods for treating type 1 and type 2 diabetes and related disorders (2025-02-04),

3. 11981931 - Reprogramming progenitor compositions and methods of use thereof (2024-05-14),

4. 11760977 - Compositions and methods for organoid generation and disease modeling (2023-09-19),

5. 11685901 - Compositions and methods for organoid generation and disease modeling (2023-06-27),

6. 11542309 - Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose (2023-01-03),

7. 11440889 - Analogs of fexaramine and methods of making and using (2022-09-13),

8. 11428697 - Compositions and methods for treating age-related diabetes and related disorders (2022-08-30),

9. 11376264 - Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment (2022-07-05),

10. 10920199 - Reprogramming progenitor compositions and methods of use therefore (2021-02-16),

11. 10912800 - Compositions and methods for treating type 1 and type 2 diabetes and related disorders (2021-02-09),

12. 10815203 - Analogs of fexaramine and methods of making and using (2020-10-27),

13. 10695404 - Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs (2020-06-30),

14. 10539572 - Compositions and methods for treating age-related diabetes and related disorders (2020-01-21),

15. 10450277 - Analogs of fexaramine and methods of making and using (2019-10-22),

Title: The Innovative Journey of Annette R Atkins

Introduction: Annette R Atkins, a pioneering inventor based in La Jolla, CA, has made significant contributions to the world of technology through her groundbreaking innovations.

Latest Patents: Annette R Atkins holds several patents in the field of biotechnology, including a recent patent for a novel method of detecting genetic mutations in cancer cells.

Career Highlights: With a career spanning over two decades, Annette R Atkins has worked tirelessly to push the boundaries of scientific discovery. Her work has been instrumental in advancing personalized medicine and improving patient outcomes.

Collaborations: Throughout her career, Annette R Atkins has collaborated with leading researchers, scientists, and medical professionals to bring her inventions to life. Her collaborative spirit has been key to the success of many of her projects.

Conclusion: Annette R Atkins stands as a shining example of innovation and dedication in the field of biotechnology. Her passion for pushing the limits of what is possible has led to groundbreaking discoveries that have the potential to change the lives of countless individuals.

Profile summary based on public USPTO records.